Sandesh Seth Actinium Pharmaceuticals, Inc. (ATNM) insider trading activity

ATNM Quotes by TradingView

Sandesh Seth is Chief Executive Officer of Actinium Pharmaceuticals, Inc.. Currently has a direct ownership of 184,481 shares of ATNM, which is worth approximately $239,825. The most recent transaction as insider was on Aug 18, 2025, when has been sold 120,900 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $206,739. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 184K
0% 3M change
39.59% 12M change
Total Value Held $239,825

SANDESH SETH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2025
SELL
Payment of exercise price or tax liability
$206,739 $1.71 p/Share
120,900 Reduced 39.59%
184,481 Common Stock
Aug 17 2022
BUY
Grant, award, or other acquisition
-
300,000 Added 49.56%
305,381 Common Stock
SS

Sandesh Seth

Chief Executive Officer
New York,, NY

Track Institutional and Insider Activities on ATNM

Follow Actinium Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNM shares.

Notify only if

Insider Trading

Get notified when an Actinium Pharmaceuticals, Inc. insider buys or sells ATNM shares.

Notify only if

News

Receive news related to Actinium Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATNM